United States · FDA National Drug Code directory
Mytox 6021
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63083-6021_f48bbd72-9f6f-4aa4-8777-d02e3830d7c6
- Product NDC
- 63083-6021
- Form
- LIQUID
- Composition / generic term
- Mytox
- Labeler
- Professional Complementary Health Formulas
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start / end (source format)
- 19840815
- Source listing expiry
- 20271231
Source-listed ingredients
- SODIUM BORATE — 4 [hp_X]/59mL
- COLCHICUM AUTUMNALE BULB — 4 [hp_X]/59mL
- AMANITA MUSCARIA FRUITING BODY — 6 [hp_X]/59mL
- ARSENIC TRIOXIDE — 6 [hp_X]/59mL
- DROSERA ROTUNDIFOLIA WHOLE — 6 [hp_X]/59mL
- BUFO BUFO CUTANEOUS GLAND — 8 [hp_X]/59mL
- UBIDECARENONE — 12 [hp_X]/59mL
These values do not establish equivalence or a dose recommendation.
Packages
- 59 mL in 1 BOTTLE, DROPPER (63083-6021-2) · 63083-6021-2
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →